BGI Genomics Co., Ltd. (SHE:300676)

Market Cap	19.31B +25.5%
Revenue (ttm)	3.71B -7.9%
Net Income	-799.91M
EPS	-1.93
Shares Out	383.85M
PE Ratio	n/a
Forward PE	768.30
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,747,201
Average Volume	15,520,098
Open	51.80
Previous Close	50.30
Day's Range	49.25 - 51.80
52-Week Range	39.00 - 70.30
Beta	0.82
RSI	48.70
Earnings Date	Apr 25, 2026

About BGI Genomics

BGI Genomics Co., Ltd. engages in the provision of genomic sequencing services and proteomic services to academic institutions, pharmaceutical companies, health care providers and other organizations in China and internationally. The company offers DNA sequencing services covering whole genome sequencing, plant/animal whole genome sequencing, exome sequencing, de novo sequencing, and metagenomic sequencing; and mass spectrometry services, such as proteomic services and biologics characterization services. It also provides diagnostics and precis...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1999
• Employees: 3,702
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300676